<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04915105</url>
  </required_header>
  <id_info>
    <org_study_id>CE20043B</org_study_id>
    <nct_id>NCT04915105</nct_id>
  </id_info>
  <brief_title>Personal Precise Treatment on Psoriasis and Psoriatic Arthritis</brief_title>
  <official_title>Personal Precise Treatment on Psoriasis and Psoriatic Arthritis and Investigate the Mechanisms of Biological Agents Induced Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Part of psoriasis and psoriatic arthritis patients treated with biologics and met primary&#xD;
      failure. Therefore, we are going to create a cell based platform to evaluate the treatment&#xD;
      effects of different biologics on psoriasis and psoriatic arthritis patients before&#xD;
      prescribed by physicians&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PBMCs isolated from psoriasis and psoriatic arthritis and incubated with Group A&#xD;
      streptococcus and different biologics for 24 hours. Cytokines expression in the culture&#xD;
      supernatants will be measured and the data can be reference for physician's prescription.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 31, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PASI score</measure>
    <time_frame>2 weeks to 3 months</time_frame>
    <description>Psoriasis skin condition and severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>swelling joint count and tenderness joint count</measure>
    <time_frame>2 weeks to 3 months</time_frame>
    <description>PSA severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>3-6 months</time_frame>
    <description>blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DLQI</measure>
    <time_frame>6 months</time_frame>
    <description>paper to investigate patient life quality</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Dermatologic Disease</condition>
  <arm_group>
    <arm_group_label>Prescreen on psoriasis and psoriatic arthritis treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prescreen markers from individual PBMCs and choose proper biologics before starting treatment on psoriasis and psoriatic arthritis patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Markers data from PBMCs</intervention_name>
    <description>Prescreen markers from patient individual PBMCs treating with streptococcus and different biologics.</description>
    <arm_group_label>Prescreen on psoriasis and psoriatic arthritis treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Healthy control without underline disease such as psoriasis and psoriatic&#xD;
             arthritis. 2. Psoriasis been diagnosed for over six months and PASI &gt;10. 3.Psoriatic&#xD;
             arthritis been diagnosed for over six months and &gt;1 swallow and tender joints&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  nil&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chung-Yang Yen, MDPhD</last_name>
    <role>Study Chair</role>
    <affiliation>Attending Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chung-Yang Yen, MDPhD</last_name>
    <phone>886423592525</phone>
    <phone_ext>5304</phone_ext>
    <email>vernayen@yahoo.com.tw</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PSO, PSA, SLE, PBMC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Psoriatic</mesh_term>
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

